Literature DB >> 35082614

Follicular Dowling-Degos Disease with Hidradenitis Suppurativa: A Case Report and Review of the Literature.

Ya-Nin Nokdhes1, Thanachat Rutnumnoi1, Poramin Patthamalai1, Charussri Leeyaphan1.   

Abstract

Dowling-Degos disease (DDD) is an autosomal dominant disorder with variable phenotypic expression. Classically, DDD is characterized by progressive reticulate hyperpigmentation on flexures with perioral pitted scars and comedone-like hyperkeratotic papules. Follicular DDD is a rare variant which was introduced by Singh et al. [Indian J Dermatol Venereol Leprol. 2013 Nov-Dec;79(6):802-4]. Follicular DDD differs from other variants because of its notable comedone-like hyperkeratotic hyperpigmented papules and a distinct histopathology which demonstrates pigmented filiform and branching rete pegs originating at the follicular infundibulum with many epidermal horn cysts while the interfollicular epidermis is essentially normal. Hereby, we present a case of follicular DDD with hidradenitis suppurativa (HS). A 37-year-old Thai man presented with slowly progressive hyperpigmented comedone-like papules on the face, neck, axillae, upper trunk, and buttocks with perioral pitted scars. Punch biopsy from a comedonal lesion on his back was consistent with follicular DDD. He also had recurrent painful nodules and abscess on the back, groin, and buttock which matched the clinical criteria for the diagnosis of HS. To date, a paucity of concurrent DDD with HS has been reported. Recent genetic studies speculate a shared pathophysiologic mechanism of DDD and HS.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Acne; Follicular Dowling-Degos disease; Hidradenitis suppurativa

Year:  2021        PMID: 35082614      PMCID: PMC8739630          DOI: 10.1159/000520541

Source DB:  PubMed          Journal:  Case Rep Dermatol        ISSN: 1662-6567


Introduction

Dowling-Degos disease (DDD) is a progressive reticulate pigmentary disorder first reported by Dowling and Freudenthal [1] and Degos and Ossipowski [2], respectively. It usually is inherited in an autosomal dominant pattern; however, some cases are sporadic [3]. The main genetic mutation associated with DDD is KRT5. Keratin 5 is an element in the cytoskeleton of basal keratinocytes. To date, many genetic mutations have been documented such as POFUT1, POGLUT1, and PSENEN [3]. DDD has multiple variants of DDD including classic DDD, generalized DDD, Galli-Galli disease, Haber's syndrome, pigmentatio reticularis faciei et colli, and follicular DDD [4]. According to literature reviews, DDD has been found to be associated with severe nodulocystic acne, hidradenitis suppurativa (HS), chloracne-like lesions, seborrheic keratoses, dystrophic fingernails, and an accessory tragus [3, 5]. DDD is known to be resistant to treatment, and no standard treatment has been established [3].

Case Report

A 37-year-old Thai man with an underlying disease of hepatitis C cirrhosis presented with slowly progressive hyperpigmented comedone-like papules on the face, neck, axillae, upper trunk, groin, and buttocks with perioral pitted scars and numerous atrophic scars. The skin lesions first appeared 22 years ago. They were mostly asymptomatic, so he did not seek any treatment. There were a few times when he experienced some painful nodules and abscess on his back, groin, and buttock which healed with atrophic scars. On one occasion, he had a tender nodule with pus around his anus which later on was diagnosed as perianal abscess. He received oral antibiotics and did not require surgery. He denied anyone in his family having similar symptoms. Upon examination, he had numerous hyperpigmented macules and papules with numerous open comedones and atrophic scars on the face, neck, chest, axillae, upper back, groin, and buttocks with few painful nodules on his back, groin, and buttock (shown in Fig. 1). No pus, discharge, or sinus tracts were found. Other mucosa, palms, soles, hair, and nails were normal.
Fig. 1

The patient had numerous hyperpigmented macules and papules with numerous open comedones and atrophic scars on the chest (a) and few tender erythematous nodules on the back (b) and both buttocks (c). d He also had hyperpigmented macules on both axillae.

Histopathology from a comedonal lesion at the back revealed dilated follicular infundibulum filled with keratin with filiform-like rete ridges and increased basal melanin pigmentation involving follicular area while interfollicular epithelium remains normal (shown in Fig. 2). Considering the history, clinical presentation, and histopathology, this patient was diagnosed with follicular DDD with HS. In terms of treatment, he received anti-acne lotion which is a mixture of 1% resorcinol, 1% salicylic acid, and 6.7% zinc oxide. The patient did not come for follow-up.
Fig. 2

a Histopathology from a comedonal lesion on the back at scanning power revealed dilated follicular infundibulum filled with keratin and filiform-like rete ridges involving follicular area while interfollicular epithelium remains normal. b, c, d Medium- and high-power examination showed filiform-like rete ridges with basal hyperpigmentation.

Discussion

DDD is an uncommon autosomal dominant genodermatosis affecting individuals during the third to fourth decade of life with progressive hyperpigmented macules and papules with hyperkeratosis [6]. Lesions initially appear on axillae and groins followed by intergluteal, inframammary folds, neck, trunk, and upper extremities. Most patients are asymptomatic, but few have pruritus on the affected area. At the present, several variations of clinical, histopathology, and genetic mutations have been described such as classic DDD, generalized DDD, follicular DDD, and Galli-Galli disease [3, 4]. Our patient presented with slowly progressive hyperpigmented macules and papules with numerous open comedones and atrophic scars on the face, neck, chest, axillae, upper back, and buttock since he was 15 years old. Differential diagnosis at first included HS and familial dyskeratotic comedones. Familial dyskeratotic comedones present at puberty with numerous, discrete, disseminate, open comedones that can heal with scar on the trunk, arms, leg, and shaft of the penis, sparing the palms and soles [7]. These features seem similar to our patient. However, in familial dyskeratotic comedones, the histopathology only shows dyskeratosis and invaginations into the dermis with occasional acantholysis which is not seen in our patient. Therefore, this patient was diagnosed with follicular DDD. Moreover, this patient also had recurrent painful nodules and abscess with multiple atrophic scars on the back, buttock, and perianal area which is not found in DDD alone. These clinical features were consistent with all 3 criteria of HS including one or more typical lesion, typical distribution, and recurrence of symptoms [8]. Typical lesions of HS are painful nodules, abscess, sinus tracts, double-open comedones, and bridges scars. Therefore, we concluded that our patient had concurrent DDD and HS. To our knowledge, 12 cases (including our case) have been reported so far (shown in Table 1) [4, 5, 9, 10, 11, 12]. All cases had clinical and histopathology characteristic of follicular DDD. Dermoscopic examination demonstrated brown pigmented Chinese letter pattern or irregular star shape, central brown hyperkeratotic follicular plugs, and comedones [9]. However, half of the reported cases did not have hyperpigmented macules and papules on flexural areas. Interestingly, most cases of follicular DDD present around childhood and puberty while classic DDD commonly presents after puberty. Additional features include ichthyosis vulgaris, lichen planus, HS, and blepharophimosis-ptosis-epicanthus inversus syndrome [5, 10, 11, 12].
Table 1

Case reports of follicular Dowling-Degos disease

Case no. [Refs.]SexAge of onset, yearsAge, yearsFamily historyAssociated disease
1 [5]Male1025YesIchthyosis vulgaris
2 [5]Female519Yesn/a
3 [4]FemalePuberty32Yesn/a
4 [4]FemalePuberty12Yesn/a
5 [9]Female2335Yesn/a
6 [9]Female2743Yesn/a
7 [9]Male3654Yesn/a
8 [10]Female1530YesHidradenitis suppurativa
9 [11]FemaleChildhood29NoBlepharophimosis-ptosis-epicanthus inversus syndrome
10 [12]MaleChildhood28YesLichen planus
11 [12]MaleChildhood23YesLichen planus
12 (our case)Male1537NoHidradenitis suppurativa

n/a, not available.

HS is a chronic inflammatory disorder of the hair and follicles typically involving axillae, buttocks, groin, perineal, and inframammary regions [8]. According to case reports and clinical studies, concurrent DDD with HS has been reported in 53 cases (including our case) as shown in Table 2 [10, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33]: 2 cases of which are follicular DDD variant and 1 case is associated with Galli-Galli disease, a variant of DDD [10, 33]. Most cases reported were of female predominance and more than half presented with at least Hurley stage 2. Almost all had a family history of HS. Recent genetic studies have found that patients with concurrent DDD with HS mostly have mutation in PSENEN, followed by POFUT1 and a case of NCSTN [13, 14, 25, 27, 28, 31]. Few cases reported association with squamous cell carcinoma, keratoacanthoma, and arthritis [17, 19, 22, 23, 30].
Table 2

Reported cases and clinical studies of concurrent Dowling-Degos disease with hidradenitis suppurativa

Case no. [Refs.]SexAge, yearsFamily history of DDDFamily history of HSGenetic mutationAssociated disease
1–15 [24]8 female/7 male43.2±12.369 yes/6 noYesn/an/a
16–20 [25]3 female/2 malen/an/an/a PSENEN n/a
21 [26]Male47NoYesn/an/a
22 [27]Male54NoYes NCSTN n/a
23–26 [14]3 female/1 malen/aYesYes PSENEN n/a
27 [13]Female33n/an/a POFUT1 n/a
28 [28]Male31YesYes PSENEN n/a
29–30 [29]2 female39/45YesYesn/an/a
31 [30]Female40YesYesn/aArthritis
32 [31]Female34YesYes POFUT1 n/a
33 [32]Female38YesYesn/an/a
34a [10]Female30YesNon/an/a
35 [15]Female43YesYesn/an/a
36 [16]Female44YesYesn/an/a
37–38 [17]2 female23/48YesYesn/aArthritis
39 [18]Female49YesYesn/an/a
40 [19]Male68NoYesn/aSCC
41b [33]Female33NoNon/an/a
42 [23]n/an/an/an/an/aSCC
43 [20]Female39n/an/an/an/a
44 [22]Female38n/an/an/aKA
45–52 [21]n/an/an/an/an/an/a
53a (Our case)Male37NoNon/an/a

n/a, not available; SCC, squamous cell carcinoma; KA, keratoacanthoma.

Follicular DDD.

Galli-Galli disease.

In 2017, Pavolsky et al. [14] discovered that patients who presented with features of both DDD and HS have heterozygous mutation in PSENEN. A year later, González-Villanueva et al. [13] found that POFUT1 mutation is associated with combined DDD and HS as well. Lately, NCSTN mutation was found in a concurrent DDD with HS patient [27]. All PSENEN and POFUT1 are critical genes that regulate the Notch signaling pathway and have been speculated to be the pathophysiologic mechanisms of patients with combined DDD and HS [3]. However, NCSTN may not have a direct effect on the NOTCH pathway but is believed to stimulate inflammatory response via type I interferon gene expression [27]. As other variants of DDD, follicular DDD is also resistant to treatment. Oral isotretinoin has been prescribed in many cases and had shown to reduce follicular lesions and comedones. However, when discontinued, follicular DDD relapses [9]. Other treatments include topical hydroquinone, retinoids, and corticosteroids [6]. In conclusion, follicular DDD, a new variant of DDD, is diagnosed based on clinical characteristics and distinct histopathology. Concurrent DDD with HS was reported increasingly. Further studies are needed to clearly explain the pathophysiology and genetic mutation involved.

Statement of Ethics

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. The study has been done according to the Declaration of Helsinki. Ethical approval was not required for this study in accordance with national guidelines.

Conflict of Interest Statement

The authors have no conflicts of interest to declare.

Funding Sources

No funding was received.

Author Contributions

All authors participated in writing and are fully responsible for the manuscript.

Data Availability Statement

All data supporting this study are available from Dr. Charussri Leeyaphan upon request.
  31 in total

1.  [Reticulated pigmentary dermatosis of the folds: relation to acanthosis nigricans].

Authors:  R DEGOS; B OSSIPOWSKI
Journal:  Ann Dermatol Syphiligr (Paris)       Date:  1954 Mar-Apr

2.  Dowling-Degos disease, hidradenitis suppurativa and arthritis in mother and daughter.

Authors:  R Dixit; R George; M Jacob; T D Sudarsanam; D Danda
Journal:  Clin Exp Dermatol       Date:  2006-05       Impact factor: 3.470

Review 3.  Dowling-Degos Disease and Hidradenitis Suppurativa. Epidemiological and Clinical Study of 15 Patients and Review of the Literature.

Authors:  Eugenia Agut-Busquet; Iris González-Villanueva; Jorge Romani de Gabriel; Jose Carlos Pascual; Miquel Ribera Pibernat; Jesús Luelmo
Journal:  Acta Derm Venereol       Date:  2019-09-01       Impact factor: 4.437

4.  [Reticular pigmented anomaly of the flexures. Dowling-Degos disease of the intertrigo type in association with acne inversa].

Authors:  D Kleeman; R M Trüeb; P Schmid-Grendelmeier
Journal:  Hautarzt       Date:  2001-07       Impact factor: 0.751

5.  Novel POFUT1 mutation associated with hidradenitis suppurativa-Dowling-Degos disease firm up a role for Notch signalling in the pathogenesis of this disorder.

Authors:  I González-Villanueva; M Gutiérrez; P Hispán; I Betlloch; J C Pascual
Journal:  Br J Dermatol       Date:  2018-02-15       Impact factor: 9.302

6.  [Dowling-Degos disease and Verneuil disease].

Authors:  L Balus; M Fazio; A Amantea; G Menaguale
Journal:  Ann Dermatol Venereol       Date:  1993       Impact factor: 0.777

7.  The deregulation of NOTCH pathway, inflammatory cytokines, and keratinization genes in two Dowling-Degos disease patients with hidradenitis suppurativa.

Authors:  Ricardo Cortez Cardoso Penha; Rita Fernanda Cortez de Almeida; Juliana Câmara Mariz; Lilian Brewer Lisboa; Lívia do Nascimento Barbosa; Roberto Souto da Silva
Journal:  Am J Med Genet A       Date:  2020-08-17       Impact factor: 2.802

Review 8.  Dowling-Degos disease: a review.

Authors:  Carla Stephan; Mazen Kurban; Ossama Abbas
Journal:  Int J Dermatol       Date:  2020-12-23       Impact factor: 2.736

9.  Dowling-Degos disease and hidradenitis suppurativa: Co occurrence or association?

Authors:  Sanjiv V Choudhary; Divya Jain; Piyush Agrawal; Adarshlata Singh
Journal:  Indian Dermatol Online J       Date:  2013-07
View more
  1 in total

1.  Follicular Dowling-Degos Disease Camouflaged as Comedones: A Case Report and Literature Review.

Authors:  Arundhathi S; Poongodi Rajagopal; Hima Gopinath; Jami Rupa Ramani
Journal:  Cureus       Date:  2022-06-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.